Your browser doesn't support javascript.
loading
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Bruzzese, Antonella; Derudas, Daniele; Galli, Monica; Martino, Enrica Antonia; Rocco, Stefano; Conticello, Concetta; Califano, Catello; Giuliani, Nicola; Mangiacavalli, Silvia; Farina, Giuliana; Lombardo, Alessandra; Brunori, Marino; Rossi, Elena; Antonioli, Elisabetta; Ria, Roberto; Zambello, Renato; Di Renzo, Nicola; Mele, Giuseppe; Marcacci, Gianpaolo; Pietrantuono, Giuseppe; Palumbo, Gaetano; Cascavilla, Nicola; Cerchione, Claudio; Belotti, Angelo; Criscuolo, Clelia; Uccello, Giuseppina; Curci, Paola; Vigna, Ernesto; Mendicino, Francesco; Iaccino, Enrico; Mimmi, Selena; Botta, Cirino; Vincelli, Donatella; Sgherza, Nicola; Bonalumi, Angela; Cupelli, Luca; Stocchi, Raffaella; Martino, Massimo; Ballanti, Stelvio; Gangemi, Dominella; Gagliardi, Alfredo; Gamberi, Barbara; Pompa, Alessandra; Tripepi, Giovanni; Frigeri, Ferdinando; Consoli, Ugo; Bringhen, Sara; Zamagni, Elena; Patriarca, Francesca; De Stefano, Valerio.
Afiliação
  • Bruzzese A; Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
  • Derudas D; Department of Hematology, Businco Hospital, Cagliari, Italy.
  • Galli M; Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale-Papa Giovanni XXIII, Bergamo, Italy.
  • Martino EA; Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
  • Rocco S; Hematology Unit, Napoli, Italy.
  • Conticello C; Department of Medical and Surgical Specialties, Hematology Section, University of Catania, Catania, Italy.
  • Califano C; Onco-hematology Unit, Ospedale Umberto I, Nocera Inferiore, Italy.
  • Giuliani N; Hematology Unit, Parma University Hospital, Parma, Italy.
  • Mangiacavalli S; Department of Hematology-Oncology, Hematology Division, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
  • Farina G; UOC Ematologia a Indirizzo Oncologico, AORN "Sant'Anna e San Sebastiano", Caserta, Italy.
  • Lombardo A; Onco-hematology Unit Azienda Ospedaliera Santa Maria of Terni, Terni, Italy.
  • Brunori M; Internal Medicine, Ospedale S. Croce, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Fano, Italy.
  • Rossi E; Istituto di Ematologia, Università Cattolica, Fondazione Policlinico Gemelli IRCCS, Roma, Italy.
  • Antonioli E; Hematology Unit, Careggi Hospital, Florence, Italy.
  • Ria R; Department of Biomedical Science, University of Bari "Aldo Moro" Medical School, Internal Medicine "G. Baccelli", Bari, Italy.
  • Zambello R; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
  • Di Renzo N; Hematology Unit, Lecce, Italy.
  • Mele G; Hematology Unit, Brindisi, Italy.
  • Marcacci G; Hematology and Bone Marrow Transplant Unit, Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS, Napoli, Italy.
  • Pietrantuono G; Unit of Hematology and Stem Cell Transplantation, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture (Pz), Italy.
  • Palumbo G; Department of Hematology, Hospital University Riuniti, Foggia, Italy.
  • Cascavilla N; Department of Hematology and Bone Marrow Transplant, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Cerchione C; Hematology Unit, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.
  • Belotti A; Hematology Unit, A.O. Spedali Civili, Brescia, Italy.
  • Criscuolo C; Hematology Unit, AO S.G. Moscati, Aversa (CE), Italy.
  • Uccello G; Hematology Department, G. Garibaldi Hospital, Catania, Italy.
  • Curci P; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
  • Vigna E; Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
  • Mendicino F; Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
  • Iaccino E; Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Mimmi S; Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Botta C; Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
  • Vincelli D; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Sgherza N; Department of Hemato-Oncology and Radiotherapy, Hematology Unit, Great Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
  • Bonalumi A; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
  • Cupelli L; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Stocchi R; Hematology Unit and Pathology Department, S. Eugenio Hospital Rome, Rome, Italy.
  • Martino M; Hematology, DISM, University of Udine, Udine, Italy.
  • Ballanti S; Department of Hemato-Oncology and Radiotherapy, Stem Cell Transplantation Unit, Great Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
  • Gangemi D; Institute of Haematology and Stem Cell Transplantation, Ospedale Santa Maria della Misericordia, University of Perugia, Perugia, Italy.
  • Gagliardi A; Hematology Unit, Fabrizio Spaziani Hospital, Frosinone, Italy.
  • Gamberi B; Complex Operative Unit of Hematology, S. Maria di Loreto Nuovo Hospital, Napoli, Italy.
  • Pompa A; Hematology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
  • Tripepi G; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
  • Frigeri F; Nephrology Center of National Research Institute of Biomedicine and Molecular Immunology, Reggio Calabria, Italy.
  • Consoli U; UOC Ematologia a Indirizzo Oncologico, AORN "Sant'Anna e San Sebastiano", Caserta, Italy.
  • Bringhen S; Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Zamagni E; Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
  • Patriarca F; Seràgnoli Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy.
  • De Stefano V; Hematology, DISM, University of Udine, Udine, Italy.
Hematol Oncol ; 40(4): 704-715, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35608183
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália